Camtek Hits Record Revenue but Here's Why One Fund Still Cut $3 Million Amid a 30% Run

First Wilshire Securities Management reduced its Camtek (NASDAQ:CAMT) position by 81,598 shares in Q3, cutting the stake to 206,424 shares with a quarter-end value of $21.68 million — a reported ~$2.67 million reduction that represents a 1.94% shift in the fund's reportable AUM and leaves Camtek as roughly 5.8% of its 13F AUM. Camtek posted record Q3 revenue of $126 million (up 12% YoY), non-GAAP operating margins near 30%, and sees full-year revenue around $495 million (about 15% above prior year); shares trade near $109.14 with a ~$5 billion market cap. The sale reads as portfolio discipline and profit-taking rather than a change in fundamental outlook given strong earnings and AI-driven advanced-packaging demand, implying limited broader market impact but continued idiosyncratic volatility.

Analysis

Market structure: Camtek (CAMT) is a direct beneficiary of AI-driven advanced-packaging demand — winners include OSATs and niche metrology suppliers while incumbents with broader exposure (large fabs/equipment OEMs) see less incremental share gain here. First Wilshire’s 81.6k-share trim (~$2.7M) is portfolio risk-taking, not sector demand deterioration: a 15% Y/Y revenue guide to ~$495M implies order momentum and pricing power for proprietary inspection systems. Cross-asset effects are modest — stronger capex signals tighten high-yield spreads and lift tech equities; expect a 5–15% near-term knee-jerk volatility in CAMT equity and options IV rather than macro FX or commodity moves.

Risk assessment: Key tail risks are China export controls or a sudden cut in AI packaging capex that could swing backlog conversion and revenue by >20% in 12 months; product defects or single-customer concentration could knock margins 5–10% quickly. Immediate (days) risk: profit-taking pushes stock 8–15% down; short-term (weeks/months): guidance or large OEM order announcements; long-term (quarters/years): structural advanced-packaging secular growth supports 15%+ CAGR if end-market AI demand persists. Hidden dependency: CAMT’s growth lever is a small number of large OSAT/foundry customers — watch order cadence and deposit schedules.

Trade implications: Direct play — constructive on CAMT but size and timing matter: prefer scaling into dips; options provide controlled exposure. Pair trades: long CAMT vs short large-cap inspection peer (e.g., KLAC) isolates advanced-packaging upside. Catalysts to trade around: quarterly results, major customer wins, and any China-related policy changes within next 90 days.

Contrarian angles: The market may be underpricing recurring software value and margin leverage — a >15% pullback would likely be overdone given cash-rich balance sheet and 30% non-GAAP margins. Historical parallels: small-cap equipment names often see episodic 20–30% drawdowns after record quarters then recover if guidance holds. Unintended consequence: concentrated retail/institutional flows could create liquidity gaps on downside; plan execution and stop levels accordingly.

Key Decisions for Investors

• Establish an initial 2–3% long position in CAMT at market (~$109) with a 12-month target of $150 (≈+37%) and a hard stop-loss at 12% below cost (~$96); revisit sizing on next quarter’s order disclosure or guidance update.
• If CAMT drops >10% from entry (<~$98) within the next 4 weeks, scale into a total 5% position (add 2–3%) — rationale: profit-taking risk vs persistent secular AI packaging demand; reassess if orders or deposits fall >20% YoY.
• Buy a defined-risk bull call spread to lever the thesis: buy CAMT 3/21/2026 110C and sell 150C (allocate premium = 1% of portfolio) — max loss = premium, max gain if CAMT >150 by expiry; use if you prefer capped downside exposure over 3 months.
• Implement a pair trade to hedge sector risk: long CAMT / short KLAC equal-dollar (1:1) sized to neutralize market beta, 6–12 month horizon; exit pair if relative CAMT outperformance exceeds 10% or if CAMT misses guidance by >5%.